You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 13, October 4, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Review
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

Probable Benefits of Increasing Folic Acid Intakes

Carol J. Boushey, PhD, MPH, RD; Shirley A. A. Beresford, PhD; Gilbert S. Omenn, MD, PhD; Arno G. Motulsky, MD

JAMA. 1995;274(13):1049-1057.


Abstract

Objective.
—To determine the risk of elevated total homocysteine (tHcy) levels for arteriosclerotic vascular disease, estimate the reduction of tHcy by folic acid, and calculate the potential reduction of coronary artery disease (CAD) mortality by increasing folic acid intake.

Data Sources.
—MEDLINE search for meta-analysis of 27 studies relating homocysteine to arteriosclerotic vascular disease and 11 studies of folic acid effects on tHcy levels.

Study Selection and Data Extraction.
—Studies dealing with CAD, cerebrovascular disease, and peripheral arterial vascular disease were selected. Three prospective and six population-based case-control studies were considered of high quality. Five cross-sectional and 13 other case-control studies were also included. Causality of tHcy's role in the pathogenesis of vascular disease was inferred because of consistency across studies by different investigators using different methods in different populations.

Data Synthesis.
—Elevations in tHcy were considered an independent graded risk factor for arteriosclerotic vascular diseases. The odds ratio (OR) for CAD of a 5-µmol/L tHcy increment is 1.6(95% confidence interval [Cl], 1.4 to 1.7) for men and 1.8 (95% Cl, 1.3 to 1.9) for women. A total of 10% of the population's CAD risk appears attributable to tHcy. The OR for cerebrovascular disease (5-µmol/L tHcy increment) is 1.5 (95% Cl, 1.3 to 1.9). Peripheral arterial disease also showed a strong association. Increased folic acid intake (approximately 200 µg/d) reduces tHcy levels by approximately 4 µmol/L. Assuming that lower tHcy levels decrease CAD mortality, we calculated the effect of (1) increased dietary folate, (2) supplementation by tablets, and (3) grain fortification. Under different assumptions, 13 500 to 50 000 CAD deaths annually could be avoided; fortification of food had the largest impact.

Conclusions.
—A 5-µmol/L tHcy increment elevates CAD risk by as much as cholesterol increases of 0.5 mmol/L (20 mg/dL). Higher folic acid intake by reducing tHcy levels promises to prevent arteriosclerotic vascular disease. Clinical trials are urgently needed. Concerns about masking cobalamin deficiency by folic acid could be lessened by adding 1 mg of cobalamin to folic acid supplements.

(JAMA. 1995;274:1049-1057)



Author Affiliations

From the Northwest Prevention Effectiveness Center (Drs Boushey, Beresford, Omenn, and Motulsky), the Nutritional Sciences Program (Drs Boushey and Beresford), and the Departments of Epidemiology (Drs Boushey and Beresford), Environmental Health (Dr Omenn), Medicine (Drs Omenn and Motulsky), and Genetics (Dr Motulsky), University of Washington, Seattle.


Footnotes

Reprint requests to Department of Epidemiology, University of Washington, Box 357236, Seattle, WA 98195-7236 (Dr Beresford).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine {beta}-Synthase-Deficient Mice
Zhang et al.
Circulation 2009;120:1893-1902.
ABSTRACT | FULL TEXT  

Novel markers of peripheral arterial disease
Khawaja and Kullo
Vasc Med 2009;14:381-392.
ABSTRACT  

Identification of dynein light chain road block-1 as a novel interaction partner with the human reduced folate carrier
Ashokkumar et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2009;297:G480-G487.
ABSTRACT | FULL TEXT  

Lack of Phosphatidylethanolamine N-Methyltransferase Alters Plasma VLDL Phospholipids and Attenuates Atherosclerosis in Mice
Zhao et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1349-1355.
ABSTRACT | FULL TEXT  

Reporting of systematic reviews of micronutrients and health: a critical appraisal
Chung et al.
Am. J. Clin. Nutr. 2009;89:1099-1113.
ABSTRACT | FULL TEXT  

Tissue methionine cycle activity and homocysteine metabolism in female rats: impact of dietary methionine and folate plus choline
Wilson et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E702-E713.
ABSTRACT | FULL TEXT  

High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis: A Randomized Controlled Trial
Hodis et al.
Stroke 2009;40:730-736.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
de Ruijter et al.
BMJ 2009;338:a3083-a3083.
ABSTRACT | FULL TEXT  

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials
Antoniades et al.
Eur Heart J 2009;30:6-15.
ABSTRACT | FULL TEXT  

Ethnicity and peripheral artery disease
Bennett et al.
QJM 2009;102:3-16.
ABSTRACT | FULL TEXT  

Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Siekmeier et al.
J CARDIOVASC PHARMACOL THER 2008;13:279-297.
ABSTRACT  

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
Kearon et al.
Blood 2008;112:4432-4436.
ABSTRACT | FULL TEXT  

Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)
Held et al.
Vasc Med 2008;13:245-253.
ABSTRACT  

Sport-related hyperhomocysteinaemia: a putative marker of muscular demand to be noted for cardiovascular risk
Borrione et al.
Br. J. Sports. Med. 2008;42:894-900.
ABSTRACT | FULL TEXT  

Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Humphrey et al.
Mayo Clin Proc. 2008;83:1203-1212.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Lower Extremity Wounds
Schwartzfarb and Romanelli
INT J LOW EXTREM WOUNDS 2008;7:126-136.
ABSTRACT  

Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial
Ebbing et al.
JAMA 2008;300:795-804.
ABSTRACT | FULL TEXT  

Plasma total homocysteine: instigator or indicator of cardiovascular disease?
Moat
Ann Clin Biochem 2008;45:345-348.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice
Zhou et al.
FASEB J. 2008;22:2569-2578.
ABSTRACT | FULL TEXT  

Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis
Li and Vance
J. Lipid Res. 2008;49:1187-1194.
ABSTRACT | FULL TEXT  

Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease: A Randomized Trial
Albert et al.
JAMA 2008;299:2027-2036.
ABSTRACT | FULL TEXT  

Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention--Wrong Again?
Lonn
JAMA 2008;299:2086-2087.
FULL TEXT  

Trends in Circulating Concentrations of Total Homocysteine among US Adolescents and Adults: Findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys
Pfeiffer et al.
Clin. Chem. 2008;54:801-813.
ABSTRACT | FULL TEXT  

Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Moens et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1971-H1977.
ABSTRACT | FULL TEXT  

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study
Mann et al.
Nephrol Dial Transplant 2008;23:645-653.
ABSTRACT | FULL TEXT  

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
Vanholder et al.
NDT Plus 2008;1:2-10.
FULL TEXT  

Intake of Folate, Vitamin B6 and Vitamin B12 and the Risk of CHD: The Japan Public Health Center-Based Prospective Study Cohort I
Ishihara et al.
J. Am. Coll. Nutr. 2008;27:127-136.
ABSTRACT | FULL TEXT  

S-Adenosylhomocysteine a better indicator of vascular disease than homocysteine?
Wagner and Koury
Am. J. Clin. Nutr. 2007;86:1581-1585.
ABSTRACT | FULL TEXT  

Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology
Vance et al.
J. Biol. Chem. 2007;282:33237-33241.
FULL TEXT  

Hyperhomocysteinemia: DNA hypomethylation and endothelial degeneration
Zou
Blood 2007;110:3495-3496.
FULL TEXT  

Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study)
Powers et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2128-2135.
ABSTRACT | FULL TEXT  

Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease: A Randomized Controlled Trial
Jamison et al.
JAMA 2007;298:1163-1170.
ABSTRACT | FULL TEXT  

B Vitamins for the Prevention of Vascular Disease: Insufficient Evidence to Justify Treatment
Baigent and Clarke
JAMA 2007;298:1212-1214.
FULL TEXT  

The heritability of plasma homocysteine, and the influence of genetic variation in the homocysteine methylation pathway
Siva et al.
QJM 2007;100:495-499.
ABSTRACT | FULL TEXT  

Testosterone regulation of renal cystathionine beta-synthase: implications for sex-dependent differences in plasma homocysteine levels
Vitvitsky et al.
Am. J. Physiol. Renal Physiol. 2007;293:F594-F600.
ABSTRACT | FULL TEXT  

Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
Urquhart et al.
J Clin Pharmacol 2007;47:991-997.
ABSTRACT | FULL TEXT  

Homocysteine and cardiovascular disease: a review of the evidence
Wierzbicki
Diabetes and Vascular Disease Research 2007;4:143-149.
ABSTRACT  

Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations
Khawaja et al.
Mayo Clin Proc. 2007;82:709-716.
ABSTRACT | FULL TEXT  

Characterization of the Role of para-Aminobenzoic Acid Biosynthesis in Folate Production by Lactococcus lactis
Wegkamp et al.
Appl. Environ. Microbiol. 2007;73:2673-2681.
ABSTRACT | FULL TEXT  

ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
Bates et al.
Vasc Med 2007;12:35-83.
 

High Prevalence of Hyperhomocysteinemia in Chinese Adults Is Associated with Low Folate, Vitamin B-12, and Vitamin B-6 Status
Hao et al.
J. Nutr. 2007;137:407-413.
ABSTRACT | FULL TEXT  

Psoriasis and Risk of Myocardial Infarction--Reply
Gelfand et al.
JAMA 2007;297:362-363.
FULL TEXT  

ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
American Society of Interventional & Therapeutic N et al.
J Am Coll Cardiol 2007;49:126-170.
FULL TEXT  

Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials
Bazzano et al.
JAMA 2006;296:2720-2726.
ABSTRACT | FULL TEXT  

Hepatic Phosphatidylethanolamine N-Methyltransferase Expression Is Increased in Diabetic Rats
Hartz et al.
J. Nutr. 2006;136:3005-3009.
ABSTRACT | FULL TEXT  

Use of the Affinity/HPLC Method for Quantitative Estimation of Folic Acid in Enriched Cereal-Grain Products
Poo-Prieto et al.
J. Nutr. 2006;136:3079-3083.
ABSTRACT | FULL TEXT  

Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC
Moshal et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;291:H2825-H2835.
ABSTRACT | FULL TEXT  

Low Micronutrient Levels as a Predictor of Incident Disability in Older Women
Bartali et al.
Arch Intern Med 2006;166:2335-2340.
ABSTRACT | FULL TEXT  

A Functional Transsulfuration Pathway in the Brain Links to Glutathione Homeostasis
Vitvitsky et al.
J. Biol. Chem. 2006;281:35785-35793.
ABSTRACT | FULL TEXT  

Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes.
Yamasaki et al.
Diabetes Care 2006;29:2445-2451.
ABSTRACT | FULL TEXT  

Allograft Vasculopathy Versus Atherosclerosis
Rahmani et al.
Circ. Res. 2006;99:801-815.
ABSTRACT | FULL TEXT  

Plasma homocysteine and cysteine levels in retinal vein occlusion.
Pinna et al.
IOVS 2006;47:4067-4071.
ABSTRACT | FULL TEXT  

Liver Choline Dehydrogenase and Kidney Betaine-Homocysteine Methyltransferase Expression Are Not Affected by Methionine or Choline Intake in Growing Rats
Slow and Garrow
J. Nutr. 2006;136:2279-2283.
ABSTRACT | FULL TEXT  

Plasma Total Homocysteine Levels in Children with Type 1 Diabetes: Relationship with Vitamin Status, Methylene Tetrahydrofolate Reductase Genotype, Disease Parameters and Coronary Risk Factors
Dinleyici et al.
J Trop Pediatr 2006;52:260-266.
ABSTRACT | FULL TEXT  

Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse
Graham et al.
Br. J. Sports. Med. 2006;40:644-648.
ABSTRACT | FULL TEXT  

Human methionine synthase reductase is a molecular chaperone for human methionine synthase
Yamada et al.
Proc. Natl. Acad. Sci. USA 2006;103:9476-9481.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Aboyans et al.
Circulation 2006;113:2623-2629.
ABSTRACT | FULL TEXT  

The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub
J. Nutr. 2006;136:1726S-1730S.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Role of Oxidative Stress in the Pathophysiological Mechanism of Erectile Dysfunction
Agarwal et al.
J Androl 2006;27:335-347.
FULL TEXT  

Confounding of the Relation between Homocysteine and Peripheral Arterial Disease by Lead, Cadmium, and Renal Function
Guallar et al.
Am J Epidemiol 2006;163:700-708.
ABSTRACT | FULL TEXT  

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
The Heart Outcomes Prevention Evaluation (HOPE) 2
NEJM 2006;354:1567-1577.
ABSTRACT | FULL TEXT  

Lactose Intolerance Symptoms Assessed by Meta-Analysis: A Grain of Truth That Leads to Exaggeration
Savaiano et al.
J. Nutr. 2006;136:1107-1113.
ABSTRACT | FULL TEXT  

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Circulation 2006;113:e409-e449.
ABSTRACT | FULL TEXT  

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis
de Silva et al.
Eur Heart J 2006;27:569-581.
ABSTRACT | FULL TEXT  

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Stroke 2006;37:577-617.
ABSTRACT | FULL TEXT  

Relation of Parity With Common Carotid Intima-Media Thickness Among Women of the Study of Health in Pomerania
Epstein
Stroke 2006;37:343-343.
FULL TEXT  

Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women
Reimann et al.
J. Nutr. 2006;136:100-105.
ABSTRACT | FULL TEXT  

Trends in Serum Folate, RBC Folate, and Circulating Total Homocysteine Concentrations in the United States: Analysis of Data from National Health and Nutrition Examination Surveys, 1988-1994, 1999-2000, and 2001-2002
Ganji and Kafai
J. Nutr. 2006;136:153-158.
ABSTRACT | FULL TEXT  

Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate
Symons et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;290:H181-H191.
ABSTRACT | FULL TEXT  

Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease
Stott et al.
Am. J. Clin. Nutr. 2005;82:1320-1326.
ABSTRACT | FULL TEXT  

Retinal Vein Occlusion, Homocysteine, and Methylene Tetrahydrofolate Reductase Genotype
McGimpsey et al.
IOVS 2005;46:4712-4716.
ABSTRACT | FULL TEXT  

Serum Homocysteine Concentration of US Adults Associated with Fortified Cereal Consumption
Song et al.
J. Am. Coll. Nutr. 2005;24:503-509.
ABSTRACT | FULL TEXT  

Prepercutaneous Coronary Intervention Plasma Homocysteine Concentration Is a Useful Predictor of Angioplasty-Induced Myocardial Damage
Brasselet et al.
Clin. Chem. 2005;51:2374-2377.
FULL TEXT  

Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus
Tso et al.
Lupus 2005;14:878-883.
ABSTRACT  

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance
Mudge et al.
Nephrol Dial Transplant 2005;20:2178-2185.
ABSTRACT | FULL TEXT  

Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation: The Role of Homocysteine
Poli et al.
Stroke 2005;36:2159-2163.
ABSTRACT | FULL TEXT  

A B12-responsive Internal Ribosome Entry Site (IRES) Element in Human Methionine Synthase
Oltean and Banerjee
J. Biol. Chem. 2005;280:32662-32668.
ABSTRACT | FULL TEXT  

High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study
Tucker et al.
Am. J. Clin. Nutr. 2005;82:627-635.
ABSTRACT | FULL TEXT  

Starting with Rosuvastatin in Primary Hyperlipidemia--: Is There More Than Lipid Lowering?
Milionis et al.
ANGIOLOGY 2005;56:585-592.
ABSTRACT  

The Role of Homocysteine in Multisystem Age-Related Problems: A Systematic Review
Kuo et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:1190-1201.
ABSTRACT | FULL TEXT  

Physiological Regulation of Phospholipid Methylation Alters Plasma Homocysteine in Mice
Jacobs et al.
J. Biol. Chem. 2005;280:28299-28305.
ABSTRACT | FULL TEXT  

Folate Deficiency-Induced Hyperhomocysteinemia Attenuates, and Folic Acid Supplementation Restores, the Functional Activities of Rat Coagulation Factors XII, X, and II
Ebbesen and Ingerslev
J. Nutr. 2005;135:1836-1840.
ABSTRACT | FULL TEXT  

Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine)
Vogel et al.
J Am Coll Cardiol 2005;46:184-221.
FULL TEXT  

Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype
Williams et al.
Am. J. Clin. Nutr. 2005;82:26-31.
ABSTRACT | FULL TEXT  

Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine
Chiuve et al.
Am. J. Clin. Nutr. 2005;82:155-162.
ABSTRACT | FULL TEXT  

Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
Kilicdag et al.
Hum Reprod 2005;20:1521-1528.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.